These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32517691)

  • 1. Duration of immunity against heterologous porcine parvovirus 1 challenge in gilts immunized with a novel subunit vaccine based on the viral protein 2.
    Garcia-Morante B; Noguera M; Klocke S; Sommer K; Bridger P
    BMC Vet Res; 2020 Jun; 16(1):184. PubMed ID: 32517691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of three commercial vaccines against porcine parvovirus 1 in pregnant gilts.
    Noguera M; Vela A; Kraft C; Chevalier M; Goutebroze S; de Paz X; Kunze M; Rathkjen P; Schacht E; Garcia-Morante B
    Vaccine; 2021 Jun; 39(29):3997-4005. PubMed ID: 34099327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gilt Vaccination with a Mixed Administration of a PRRS MLV and a PPV1 Subunit Vaccine Protects against Heterologous PRRSV1 Infection and Prevents Detrimental Effects on Piglet Performance.
    Garcia-Morante B; Friedrich R; Kaiser T; Kraft C; Bridger P; Noguera M
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32717833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
    Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
    Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field evaluation of the safety and compatibility of a combined vaccine against porcine parvovirus 1 and porcine reproductive and respiratory syndrome virus in breeding animals.
    Garcia-Morante B; Noguera M; Kraft C; Bridger P
    Porcine Health Manag; 2019; 5():28. PubMed ID: 31890252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
    Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
    Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inactivated whole-virus porcine parvovirus vaccine protects pigs against disease but does not prevent virus shedding even after homologous virus challenge.
    Foerster T; Streck AF; Speck S; Selbitz HJ; Lindner T; Truyen U
    J Gen Virol; 2016 Jun; 97(6):1408-1413. PubMed ID: 26939976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inactivated, oil-emulsion vaccine for the prevention of porcine parvovirus-induced reproductive failure.
    Wrathall AE; Wells DE; Cartwright SF; Frerichs GN
    Res Vet Sci; 1984 Mar; 36(2):136-43. PubMed ID: 6326214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the efficacy of an inactivated virus vaccine against porcine parvovirus.
    Vannier P; Brun A; Chappuis G; Reynaud G
    Ann Rech Vet; 1986; 17(4):425-32. PubMed ID: 3030182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
    Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
    Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An octavalent vaccine provides pregnant gilts protection against a highly virulent porcine parvovirus strain.
    van den Born E; van den Elzen PPM; van Kilsdonk E; Hoeijmakers MJH; Segers RPAM
    BMC Vet Res; 2020 Feb; 16(1):55. PubMed ID: 32050969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a commercial porcine reproductive and respiratory syndrome virus (PRRSV) subunit vaccine against heterologous PRRSV-1 and PRRSV-2 challenge in late-term pregnant gilts.
    Oh T; Kim H; Park KH; Jeong J; Kang I; Yang S; Chae C
    Can J Vet Res; 2019 Oct; 83(4):248-254. PubMed ID: 31571723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive performance of gilts following vaccination and subsequent heterologous challenge with European strains of porcine reproductive and respiratory syndrome virus.
    Scortti M; Prieto C; Simarro I; Castro JM
    Theriogenology; 2006 Nov; 66(8):1884-93. PubMed ID: 16806451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
    Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
    Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of a new octavalent combined Erysipelas, Parvo and Leptospira vaccine in gilts against Leptospira interrogans serovar Pomona associated disease and foetal death.
    Jacobs AA; Harks F; Hoeijmakers M; Collell M; Segers RP
    Vaccine; 2015 Jul; 33(32):3963-9. PubMed ID: 26100922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against porcine parvovirus protects against disease, but does not prevent infection and virus shedding after challenge infection with a heterologous virus strain.
    Jóźwik A; Manteufel J; Selbitz HJ; Truyen U
    J Gen Virol; 2009 Oct; 90(Pt 10):2437-2441. PubMed ID: 19535504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus.
    Opriessnig T; Fenaux M; Yu S; Evans RB; Cavanaugh D; Gallup JM; Pallares FJ; Thacker EL; Lager KM; Meng XJ; Halbur PG
    Vet Microbiol; 2004 Mar; 98(3-4):209-20. PubMed ID: 15036529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel subunit vaccine based on the viral protein 2 of porcine parvovirus: safety profile in bred pigs at different stages of the reproduction cycle and in offspring.
    Garcia-Morante B; Noguera M; Klocke S; Sommer K; Kaiser T; Haist V; Schmidt H; Bridger P
    Heliyon; 2019 Nov; 5(11):e02593. PubMed ID: 31840113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of an inactivated virus vaccine for prevention of porcine parvovirus-induced reproductive failure.
    Mengeling WL; Brown TT; Paul PS; Gutekunst DE
    Am J Vet Res; 1979 Feb; 40(2):204-7. PubMed ID: 464358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV.
    Scortti M; Prieto C; Alvarez E; Simarro I; Castro JM
    Vet Rec; 2007 Dec; 161(24):809-13. PubMed ID: 18083979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.